Diagnosis and Management of Immunotherapy-related Liver Toxicity
Immune checkpoint inhibitors have revolutionized the treatment of cancer. With the increasing use of immunotherapy, clinicians have observed that immunotherapy is often related to a spectrum of adverse events. Liver toxicity is one of the most common and severe immune-related adverse events. It is v...
Enregistré dans:
Auteurs principaux: | HUA Yuwei, ZHAO Lin |
---|---|
Format: | article |
Langue: | ZH |
Publié: |
Editorial Office of Medical Journal of Peking Union Medical College Hospital
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/fedbee7a61344b0c8c947a5280bf250b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Pan-Cancer Analysis Reveals Alternative Splicing Characteristics Associated With Immune-Related Adverse Events Elicited by Checkpoint Immunotherapy
par: Xiujing He, et autres
Publié: (2021) -
Rheumatic Manifestations and Diseases From Immune Checkpoint Inhibitors in Cancer Immunotherapy
par: Pan Shen, et autres
Publié: (2021) -
Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumab
par: Rosaria De Filippi, et autres
Publié: (2021) -
Risk factors for immune-related adverse events: what have we learned and what lies ahead?
par: Xiaoyan Liu, et autres
Publié: (2021) -
Adverse Effects and Toxicity of Immune Checkpoint Inhibitors For Patients With Urothelial Carcinoma
par: Di Wang, et autres
Publié: (2021)